Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseMultiple MyelomaStem CellsMelphalanHematologic NeoplasmsTreatment OutcomeRemission InductionCombined Modality TherapyBone Marrow TransplantationRecurrenceMyeloablative AgonistsSalvage TherapyAntineoplastic Combined Chemotherapy ProtocolsTransplantation ChimeraBusulfanDisease-Free SurvivalTissue DonorsGraft SurvivalSurvival RateCyclophosphamideRetrospective StudiesWhole-Body IrradiationHodgkin DiseaseGraft vs Leukemia EffectHematopoietic Stem Cell MobilizationSurvival AnalysisHematopoietic Stem CellsCytarabineLymphoma, Non-HodgkinEtoposideVidarabineGraft vs Tumor EffectLiver TransplantationLeukemia, Myeloid, AcuteHistocompatibility TestingCord Blood Stem Cell TransplantationVincristineImmunosuppressive AgentsCarmustineNeoplasm, ResidualPrognosisFollow-Up StudiesLeukemiaMesenchymal Stem Cell TransplantationTime FactorsMyelodysplastic SyndromesBone Marrow PurgingAntigens, CD34ThiotepaLymphocyte TransfusionHistocompatibilityLymphoma, Mantle-CellAntibodies, Monoclonal, Murine-DerivedSiblingsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaAmyloidosisCytomegalovirus InfectionsLymphoma, FollicularKidney TransplantationGranulocyte Colony-Stimulating FactorLymphocyte DepletionEmbryonic Stem CellsAntilymphocyte SerumMinor Histocompatibility AntigensT-LymphocytesAntineoplastic AgentsBoronic AcidsChimerismDexamethasoneHepatic Veno-Occlusive DiseaseLymphomaPyrazinesAcute DiseaseAdult Stem CellsAntineoplastic Agents, AlkylatingVirus ActivationThalidomideLeukemia, MyeloidLeukapheresisTransplantation ImmunologyDoxorubicinHLA AntigensLymphoma, T-Cell, PeripheralAutograftsHematologic DiseasesPrednisoneAnemia, AplasticProspective StudiesCell DifferentiationFatal OutcomeGraft RejectionImmunosuppression